300760 Stock Overview
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥258.79 |
| 52 Week High | CN¥351.60 |
| 52 Week Low | CN¥221.66 |
| Beta | 0.22 |
| 1 Month Change | -0.65% |
| 3 Month Change | -11.68% |
| 1 Year Change | -10.95% |
| 3 Year Change | -32.04% |
| 5 Year Change | 46.52% |
| Change since IPO | 268.28% |
Recent News & Updates
Does Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Have A Healthy Balance Sheet?
Dec 03
We Like Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Returns And Here's How They're Trending
Nov 18Is There An Opportunity With Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) 27% Undervaluation?
Oct 24Recent updates
Does Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Have A Healthy Balance Sheet?
Dec 03We Like Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Returns And Here's How They're Trending
Nov 18Is There An Opportunity With Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) 27% Undervaluation?
Oct 24Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Ticks All The Boxes When It Comes To Earnings Growth
Oct 08Risks To Shareholder Returns Are Elevated At These Prices For Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)
Aug 12Shareholders Would Enjoy A Repeat Of Shenzhen Mindray Bio-Medical Electronics' (SZSE:300760) Recent Growth In Returns
Jul 28Estimating The Fair Value Of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SZSE:300760)
Jun 06These 4 Measures Indicate That Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Is Using Debt Safely
May 21Analysts Have Made A Financial Statement On Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) First-Quarter Report
Apr 30Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s (SZSE:300760) Share Price Not Quite Adding Up
Apr 21Shenzhen Mindray Bio-Medical Electronics (SZSE:300760) Looks To Prolong Its Impressive Returns
Apr 02Shareholder Returns
| 300760 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 2.0% | 0.2% | -0.6% |
| 1Y | -10.9% | -11.6% | 8.3% |
Return vs Industry: 300760 matched the CN Medical Equipment industry which returned -11.6% over the past year.
Return vs Market: 300760 underperformed the CN Market which returned 8.3% over the past year.
Price Volatility
| 300760 volatility | |
|---|---|
| 300760 Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.9% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300760 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300760's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 18,044 | Hao Wu | www.mindray.com |
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions worldwide. The company offers patient monitoring and life support products, such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, endoscopes, and accessories, as well as emergency care, peri-operative care, critical care, and IT solutions.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Fundamentals Summary
| 300760 fundamental statistics | |
|---|---|
| Market cap | CN¥312.98b |
| Earnings (TTM) | CN¥12.38b |
| Revenue (TTM) | CN¥37.11b |
25.3x
P/E Ratio8.4x
P/S RatioIs 300760 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300760 income statement (TTM) | |
|---|---|
| Revenue | CN¥37.11b |
| Cost of Revenue | CN¥12.65b |
| Gross Profit | CN¥24.47b |
| Other Expenses | CN¥12.08b |
| Earnings | CN¥12.38b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 10.24 |
| Gross Margin | 65.92% |
| Net Profit Margin | 33.37% |
| Debt/Equity Ratio | 0.3% |
How did 300760 perform over the long term?
See historical performance and comparisonDividends
2.8%
Current Dividend Yield71%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 20:17 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is covered by 52 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sandra Sun | BofA Global Research |
| Zhishun Siu | CCB International Securities Limited |
| Yue Gao | Changjiang Securities Co. LTD. |